- ￥5600
- GeneTex
- 美国
- GTX84981
- 2025年07月12日
- WB, ICC/IF, ELISA
- Mouse
- Human, Mouse
企业认证
相关产品推荐更多 >
![ATF6 antibody [37-1]](https://img1.dxycdn.com/2022/0328/258/0119170546617700453-14.jpg!wh200)
![KPNA2 antibody [C3], C-term](https://img1.dxycdn.com/2022/0328/219/4603700343636200453-14.jpg!wh200)
![ROR1 antibody [2H6]](https://img1.dxycdn.com/2022/0328/171/8549176266867500453-14.jpg!wh200)
![alpha 1 Antitrypsin antibody [N1C2]](https://img1.dxycdn.com/2022/0328/291/4700410767569200453-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Mouse monoclonal Bim antibody was raised against a recombinant protein corresponding to amino acids 2 to 198 of human Bim.
- 亚型：
IgG1
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human, Mouse
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
Human
- 目录编号：
GTX84981
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Mouse
- 应用范围：
WB, ICC/IF, ELISA
- 浓度：
1 mg/ml (Please refer to the vial label for the specific concentration.)
- 靶点：
Bim
- 抗体英文名：
Bim antibody [1C2C8]
- 抗体名：
Bim 抗体 [1C2C8]
- 规格：
100 μg
ICC/IF analysis of K562 cells using GTX84981 Bim antibody [1C2C8].
Working concentration : 20 μg/ml
ICC/IF analysis of K562 cells using GTX84981 Bim antibody [1C2C8].
Working concentration : 10 μg/ml
WB analysis of (A) 5 and (B) 25 ng Bim recombinant protein using GTX84981 Bim antibody [1C2C8].
Working concentration : 1 μg/ml
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验补体成分 C6/C7/C8/C9 补体成分：C6 血清浓度(μg/ml)：60 分子量(kDa)：128 亚单位(链)及分子量(kDa)：1条 生物学活性：组成MAC，触发淋巴细胞母细胞化 补体成分：C7 血清浓度(μg/ml)：60 分子量(kDa)：121 亚单位(链)及分子量(kDa)：1条
Antibody-Based Detection of CAG Repeat Expansion Containing Genes
-revealed by the 1C2 antibody interaction—and a tendency of mutant proteins to aggregate in vitro and in vivo. To date nine polygln expansion disorders have been characterized, the list of which includes Huntington’s disease (HD) the most frequent
Immunoaffinity Methods for Purification of Complement Components and Regulators
of membrane regulators of complement and complement receptors (3 ,7 ,8 ). Proteins isolated by immunoaffinity methods, particularly on monoclonal antibody solid phases, are usually of high purity and require either no downstream processing or simple
技术资料暂无技术资料 索取技术资料
